NasdaqCM - Delayed Quote USD

Minerva Neurosciences, Inc. (NERV)

Compare
2.1750
-0.0650
(-2.90%)
At close: 4:00:00 PM EST
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
--
--
--
--
41,175.6000
Operating Expense
24,498.1740
23,119.5760
25,231.3260
45,365.6570
39,328.8530
Operating Income
-24,498.1740
-23,119.5760
-25,231.3260
-45,365.6570
1,846.7470
Net Non Operating Interest Income Expense
-5,314.9700
-6,845.5420
-6,849.6090
-6,310.8050
--
Other Income Expense
26,501.5980
-40.2350
-27.7410
-32.8460
94.0240
Pretax Income
-3,311.5460
-30,005.3530
-32,108.6760
-51,709.3080
1,940.7710
Tax Provision
--
--
--
-1,803.3560
--
Net Income Common Stockholders
-3,311.5460
-30,005.3530
-32,108.6760
-49,905.9520
1,940.7710
Diluted NI Available to Com Stockholders
-3,311.5460
-30,005.3530
-32,108.6760
-49,905.9520
1,940.7710
Basic EPS
-0.45
-4.61
-6.01
-9.35
0.40
Diluted EPS
-0.45
-4.61
-6.01
-9.35
0.40
Basic Average Shares
7,571.9010
6,506.3720
5,340.1940
5,340.1960
5,102.9640
Diluted Average Shares
7,578.8650
6,506.3720
5,340.1940
5,340.1960
5,114.6080
Total Operating Income as Reported
-24,498.1740
-23,119.5760
-25,231.3260
-45,365.6570
1,846.7470
Total Expenses
24,498.1740
23,119.5760
25,231.3260
45,365.6570
39,328.8530
Net Income from Continuing & Discontinued Operation
-3,311.5460
-30,005.3530
-32,108.6760
-49,905.9520
1,940.7710
Normalized Income
-3,234.0980
-29,965.1180
-32,080.9350
-49,874.2523
1,846.7470
Interest Income
1,679.4330
1,437.4050
556.9460
16.5160
--
Interest Expense
6,752.3750
8,282.9470
7,406.5550
6,327.3210
--
Net Interest Income
-5,314.9700
-6,845.5420
-6,849.6090
-6,310.8050
--
EBIT
3,440.8290
-21,722.4060
-24,702.1210
-45,381.9870
1,940.7710
EBITDA
3,469.6840
-21,691.4240
-24,693.6080
-45,280.2010
2,116.9480
Reconciled Depreciation
28.8550
30.9820
8.5130
101.7860
176.1770
Net Income from Continuing Operation Net Minority Interest
-3,311.5460
-30,005.3530
-32,108.6760
-49,905.9520
1,940.7710
Total Unusual Items Excluding Goodwill
-77.4480
-40.2350
-27.7410
-32.8460
94.0240
Total Unusual Items
-77.4480
-40.2350
-27.7410
-32.8460
94.0240
Normalized EBITDA
3,547.1320
-21,651.1890
-24,665.8670
-45,247.3550
2,022.9240
Tax Rate for Calcs
--
--
--
0.0000
--
Tax Effect of Unusual Items
--
--
--
-1.1463
--
-

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

PRTC PureTech Health plc
17.60
0.00%
 
IKNA Ikena Oncology, Inc.
1.5600
-2.50%
 
TBPH Theravance Biopharma, Inc.
8.78
-2.98%
 
HLVX HilleVax, Inc.
2.0500
-1.91%
 
OKUR OnKure Therapeutics, Inc.
7.43
-4.87%
 
EPIX ESSA Pharma Inc.
1.7400
-4.40%
 
SEER Seer, Inc.
2.4000
-0.41%
 
ACHL Achilles Therapeutics plc
1.1850
-0.42%
 
BOLT Bolt Biotherapeutics, Inc.
0.5387
-4.69%
 
PMVP PMV Pharmaceuticals, Inc.
1.4600
-3.31%